IMARC’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japan diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japanese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Japanese diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the Japanese diabetes epidemiology and its dynamics:
Focus of the Analysis:
- Historical, current and future prevalence of diabetes in Japan
- Historical, current and future prevalence of type-1 and type-2 diabetes in Japan
- Historical, current and future prevalence of diabetes in the urban and rural regions in Japan
- Historical, current and future prevalence of diabetes among males and females in Japan
- Historical, current and future prevalence of diabetes among various age groups in Japan
- Historical, current and future diagnosis rates for diabetes in Japan
- Historical, current and future drug treatment rates for diabetes in Japan
Comprehensive situation analysis of the Japanese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
- Performance of the Oral Antidiabetics market in Japan
- Performance of key classes
- Performance of key players
- Market outlook
Comprehensive situation analysis of the Japanese Insulin market and its dynamics:
Focus of the Analysis:
- Performance of the Insulin market in Japan
- Performance of key classes
- Performance of key players
- Market outlook
Comprehensive situation analysis of the Japanese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
- Performance of the diabetes diagnostics market in Japan
- Market Segmentation
- Key players
- Market outlook
Table of Contents
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications
4 Key Factors Driving the Diabetes Market in Japan
5 Japan Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
5.6 Diabetes Diagnosis and Drug Treatment Rates
6 Japan Diabetes Market
6.1 Historical Market Trends (2007-2014)
6.2 Market Breakup by Segment (2007-2014)
6.3 Japan Oral Antidiabetics Market
6.3.1 Historical Market Trends (2007-2014)
6.3.2 Market Breakup by Class (2007-2014)
6.3.3 Market Shares of Key Players
6.3.4 Market Outlook (2015-2020)
6.4 Japan Insulin Market
6.4.1 Historical Market Trends (2015-2020)
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook (2015-2020)
6.5 Market Outlook (2015-2020)
7 Japan Diabetes Diagnostics Market
7.1 Historical Market Trends (2007-2014)
7.2 Market Segmentation
7.3 Key Players
7.4 Market Outlook (2015-2020)
List of Figures
Figure 3 1: The Impact of Diabetes on the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: Japan: Overweight & Obese Population (in Millions), 2007, 2014 & 2020
Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2014 & 2030
Figure 5 1: Japan: Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 2: Japan: Total Number of Diabetes Patients (in Millions), 2015 – 2020
Figure 5 3: Japan (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 4: Japan (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2015 – 2020
Figure 5 5: Japan (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 6: Japan (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2015 – 2020
Figure 5 7: Japan (Male & Female): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 8: Japan (Male & Female): Total Number of Diabetes Patients (in Millions), 2015 – 2020
Figure 5 9: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2007- 2014
Figure 5 10: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2015 – 2020
Figure 5 11: Japan: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2007- 2014
Figure 5 12: Japan: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2015 – 2020
Figure 6 1: Japan: Diabetes Market (in Million US$), 2007-2014
Figure 6 2: Japan: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2007-2014
Figure 6 3: Japan: Oral Antidiabetics Market (in Million US$), 2007-2014
Figure 6 4: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2007-2014
Figure 6 5: Japan: Oral Antidiabetics Market: Sales Share of Key Players (in %)
Figure 6 6: Japan: Oral Antidiabetics Market Forecast (in Million US$), 2015-2020
Figure 6 7: Japan: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020
Figure 6 8: Japan: Insulin Market (in Million US$), 2007-2014
Figure 6 9: Japan: Insulin Market: Sales Share of Key Classes (in %), 2014
Figure 6 10: Japan: Insulin Market: Sales Share of Key Players (in %)
Figure 6 11: Japan: Insulin Market Forecast (in Million US$), 2015-2020
Figure 6 12: Japan: Insulin Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020
Figure 6 13: Japan: Diabetes Market Forecast (in Million US$), 2015-2020
Figure 6 14: Japan: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2015-2020
Figure 7 1: Japan: Diabetes Diagnostics Market (in Million US$), 2007-2014
Figure 7 2: Japan: Diabetes Diagnostics Market Forecast (in Million US$), 2015-2020
List of Tables
Table 2 1: Japan: Diabetes Epidemiology: Executive Summary
Table 2 2: Japan: Diabetes Market: Executive Summary
Table 3 1: Diagnosis of Diabetes
Table 4 1: Japan: Overweight & Obesity Statistics, 2006, 2010 & 2014
Table 4 2: Japan: Urban & Rural Population Breakup (in Millions), 1991, 2001, 2011 & 2014
Table 4 3: Global: Diabetes Population Breakup by Country (in 000’s), 2014 & 2020
Table 4 4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 5 1: Japan: Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
Table 5 2: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
Table 5 3: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
Table 5 4: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2007, 2014 & 2020
Table 5 6: Japan: Total Diagnosed & Drug Treated Diabetes Population, 2007, 2014 & 2020
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/japan-diabetes-market
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
To know more about our company, please visit: http://www.imarcgroup.com/
Company Name: IMARC Group
Contact Person: Krishna Sharma
Email:Send Email
Phone: +91-120-415-5099
Address:G B Nagar Noida Complex
City: Noida
State: Uttar Pradesh
Country: India
Website: http://www.imarcgroup.com/
